ODI PHARMA AB (6OD) — Cash Flow Quality Index
Latest as of June 2026:
2.38x
ODI PHARMA AB (6OD) has a Cash Flow Quality Index of 2.38x as of June 2026. Operating cash flow of €364.19K exceeds net income of €153.04K, indicating high earnings quality where cash backs reported profits. Explore ODI PHARMA AB debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
2.38x
Operating CF / Net Income
Operating Cash Flow
€364.19K
EUR
Net Income
€153.04K
EUR
Data as of
Jun 2026
Most recent filing
ODI PHARMA AB Cash Flow Quality Index (2026–2026)
Historical Cash Flow Quality Index for ODI PHARMA AB across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does ODI PHARMA AB generate cash.
Annual Cash Flow Quality Index for ODI PHARMA AB (2026–2026)
Year-by-year earnings quality comparison for ODI PHARMA AB.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 2.30x | €4.58 Million | €1.99 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.